Liraglutide + PYY(3-36) Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements

Background: Treatment options for NAFLD are still limited. Bariatric surgery, such as Roux-en-Y gastric bypass (RYGB), has been shown to improve metabolic and histologic markers of NAFLD. Glucagon-like-peptide-1 (GLP-1) analogues lead to improvements in phase 2 clinical trials. We directly compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Metzner, Valentin, Herzog, Gloria, Heckel, Tobias, Bischler, Thorsten, Hasinger, Julia, Otto, Christoph, Fassnacht, Martin, Geier, Andreas, Seyfried, Florian, Dischinger, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836549/
https://www.ncbi.nlm.nih.gov/pubmed/35160204
http://dx.doi.org/10.3390/jcm11030753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836549/
https://www.ncbi.nlm.nih.gov/pubmed/35160204
http://dx.doi.org/10.3390/jcm11030753

Ejemplares similares